A Phase 2 Efficacy Study of CLS003 ICVT in Subjects With Cutaneous Warts.

Cutaneous Warts Clinical Trial

Official title:
A Phase 2, Randomized, Vehicle-Controlled, Double-Blind, Study to Evaluate Efficacy and Safety of Topical Ionic Contra-viral Therapy (ICVT) Comprised of CLS003 in Cutaneous Warts

Status Completed

Clinical Trial Summary

A phase 2, randomized, vehicle-controlled, double-blind study to assess the efficacy, safety and pharmacodynamics (PD) of topically applied CLS003 in otherwise healthy patients with cutaneous warts.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02333643
Study type	Interventional
Source	Cutanea Life Sciences, Inc.
Contact
Status	Completed
Phase	Phase 2
Start date	January 2015
Completion date	August 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05739786` - Comparisom of Liquid Nitrogen and Vitamin D3 in The Treatment of Cutaneous Warts	Phase 1
Completed	`NCT02106260` - First-in-Human Study of CLS003 ICVT in Subjects With Cutaneous Warts	Phase 1/Phase 2
Recruiting	`NCT00644579` - bLAC - Treatment of Cutaneous Warts in Immune Suppressed, Kidney Transplanted Patients	Phase 2
Completed	`NCT03846648` - CyPep-1 in Cutaneous Warts	Phase 1
Not yet recruiting	`NCT05902624` - Efficacy and Safety of Hepatitis B Virus Vaccine(HBV) in Treatment of Cutaneous Warts	Early Phase 1
Completed	`NCT05023408` - Intralesional Bleomycin Versus Cryotherapy for Treatment of Cutaneous Warts	Phase 2
Completed	`NCT05862441` - A Study to Assess the Efficacy of Omnivirol-Salicylic Acid Combination Therapy for Cutaneous Warts With Emphasis on Persistent Warts	Phase 2/Phase 3
Completed	`NCT03734003` - Infrared Bioeffect System for the Treatment of Cutaneous Warts	N/A